Fidelis Care Opens Maternal Health Grant Applications in NY
Grants aim to support innovative strategies in postpartum care and maternal mental health in underserved and vulnerable communities Fidelis Care, a statewide health plan with...
Category : Healthcare Quality, Patient Safety & Policy
CN Bio Launches Cross-Species DILI Services for Drug Development
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system...
Innovent & HUTCHMED NDA Accepted for Sintilimab Combo in China
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
Akeso’s Cadonilimab Approved for 1st-Line Cervical Cancer Treatment
Akeso, Inc. is pleased to announce that the National Medical Products Administration (NMPA) has approved the company’s first- in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, for the first-line...
Asgard Therapeutics Adds Top Experts to Board, Boosting Drug & Cancer Immunotherapy
Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announces the appointments of Dr Cristina Csimma as an independent member of...
6th Global Pharma Picks LifeSphere NavaX for GenAI Case Processing
Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies ArisGlobal, an innovative technology company at the forefront of life...
KalVista Highlights Sebetralstat’s Potential at Medical Congress
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new setralstat findings related to time to end of progression of hereditary angioedema (HAE) attacks, and the effectiveness...
Astellas, Evopoint Ink Deal for CLDN18.2 ADC XNW27011
Agreement grants Astellas exclusive worldwide rights (excluding China’s mainland, Hong Kong, Macao and Taiwan region) to develop and commercialize XNW27011 XNW27011 has demonstrated encouraging monotherapy efficacy in an ongoing Phase 1/2 study...
IonOpticks Gen 4 Aurora Sets New Benchmark in Chromatography
IonOpticks, developer of the highest-performing chromatography columns for mass spectrometry research, today announces the launch of its 4th Generation of Aurora Series columns. Following extensive...
Study Shows Ambry Genetics’ Program Impact on Rare Disease Diagnosis
Peer-reviewed publication examines the benefits of proactive exome reanalysis on diagnostic outcomes Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc., and a leader...
Mazdutide Obesity Study in China Published in NEJM
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and...
Anthem Blue Cross, Resurgens Orthopaedics Sign Multi-Year Deal
Resurgens to remain in-network for Anthem members across Georgia Anthem Blue Cross and Blue Shield announced today a new, multi-year provider network agreement with Resurgens...
Trial Shows Active Chest Tube Clearance Boosts Cardiac Outcomes
Significant Reductions in Chest Tube Clogging, Complications, and Resource Use Demonstrated in Prospective Study ClearFlow, Inc., a medical device company based in Irvine, California, announced...
ReGelTec Receives CE Mark for HYDRAFIL® System for Back Pain
Clinical data show the percutaneous disc augmentation system generated significant improvements in pain and disability scores through 2-year follow-up ReGelTec Inc., a company developing a...
Zydus Gets USFDA Approval for Generic Glatiramer Acetate Injection
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL,...